This is a snippet of the transcript, sign up to read more.
There are two significant issues. One is client acceptance, which involves various factors. Veterinarians need to feel comfortable recommending it, and clients need to perceive value in the testing. We've been doing wellness testing for about eight to 10 years, and partnering with a lab provider for a pilot study helped us a lot. We tested 100 pets we thought were healthy, and around 20% had some form of sub-clinical illness. This narrative helped convince our team of the testing's importance, which in turn helped with client acceptance. The team were able to say, Jamie's dog, for example, came in and she didn't think it was sick and then we did a test and we had some results that were concerning.
This is a snippet of the transcript, sign up to read more.
I don't think there have been dramatic changes. The last time we had a significant change in revenue was when we initiated wellness testing. Before that, we hadn't been doing it. I don't have a specific percentage, but we saw a substantial increase when we made it a priority and recommended it for all patients. Aside from that, the percentage of revenue has remained consistent in our practice. I don't anticipate dramatic shifts. There will always be opportunities to introduce new tests, which could be additive. However, I assume that 12% of our revenue is a stable number and will continue to be so for years to come.
This is a snippet of the transcript, sign up to read more.
Yes and no. We are evaluating our options because our existing agreement with IDEXX expires next month, and we had a four-year agreement with them. Historically, we've switched providers, going from IDEXX to Antech and back to IDEXX. We might switch back to Antech this time because they tend to be very competitive. If I were to renew with IDEXX, they might give me good rates, but if I'm willing to switch, I can get more incentives from the competitor. Another significant factor is our membership of VMG, that group purchasing organization I mentioned, which has selected one lab as their preferred provider. We get competitive pricing because of that, and we've used it as a negotiating tactic. Even though IDEXX isn't the preferred provider for my group, we've been able to get compelling pricing from Antech, which IDEXX was willing to match and negotiate beyond.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research